Uwe Reinhardt - Tekla Life Insider

XHQLX -- USA Fund  

USD 20.49  0.24  1.16%

  Executive
Dr. Uwe E. Reinhardt, Ph.D. is Independent Trustee of HQ Life Sciences Investors. Dr. Reinhardt is the James Madison Professor of Political Economy at Princeton University, teaching economics and public affairs since 1968, and was a member of the Institute of Medicine of the National Academy of Sciences since 1978. He serves on the Audit Committee of each Fund. Dr. Reinhardt is recognized as one of the nation leading authorities on health care economics, a prominent scholar in health care economics and a frequent speaker and author on subjects ranging from the war in Iraq to the future of Medicare. Dr. Reinhardt provides each Fund with valuable insights in healthcare economics and reform. He is a past president of the Association of Health Services Research. From 1986 to 1995 he served as a commissioner on the Physician Payment Review Committee, established in 1986 by Congress to advise it on issues related to the payment of physicians. He is a senior associate of the Judge Institute for Management of Cambridge University, UK, and a trustee of Duke University and the Duke University Health System. Dr. Reinhardt is or was a member of numerous editorial boards, among them the Journal of Health Economics, the Milbank Memorial Quarterly, Health Affairs, the New England Journal of Medicine, and the Journal of the American Medical Association
Age: 79  Executive Since 1992  Ph.D    
Reinhardt received his Ph.D. from Yale University.

Management Performance (%)

Similar Money Managers

Found 10 records

One Year Return

Michelle LouieVanguard 500 Index Institutiona
0.0%
Michelle LouieVanguard 500 Index Admiral
4.19%
Gerard OReillyVanguard Total Stock Mkt Idx Ad
3.95%
Gerard OReillyVanguard Total Stock Mkt Idx In
0.0%
Gerard OReillyVanguard Total Stock Market Idx
3.92%
Michael PerreVanguard Total Intl Stock Index
-8.92%
Gerard OReillyVanguard Total Stock Mkt Idx In
8.3%
Michelle LouieVanguard 500 Index Investor
4.07%
Gerard OReillyVanguard Total Stock Mkt Idx In
3.82%
Michael PerreVanguard Total Intl Stock Index
-8.98%

Fund Summary

The fund is listed under null category and is part of null family.

Tekla Life Sciences Leadership Team

William Reardon, Independent Trustee
Michael Bonney, Independent Trustee
Oleg Pohotsky, Independent Trustee
Lucinda Stebbins, Independent Trustee
Daniel Omstead, President Trustee
Uwe Reinhardt, Independent Trustee
Rakesh Jain, Independent Trustee

Fund Performance Indicators

Current Sentiment - XHQLX

Tekla Life Sciences Investor Sentiment

Macroaxis portfolio users are unemotional in their outlook on investing in Tekla Life Sciences Investors. What is your outlook on investing in Tekla Life Sciences Investors? Are you bullish or bearish?
Bullish
Bearish
50% Bullish
50% Bearish
Skip

Also Currentnly Active

Purchased a lot of shares of
2 days ago
Traded for 156.0
Purchased a lot of shares of
2 days ago
Traded for 156.0
Purchased over 300 shares of
2 days ago
Traded for 9.81
See also Your Current Watchlist. Please also try Cryptocurrency Arbitrage module to find pairs of digital assets on multiple exchanges that are traded at a risk free arbitrage.
Search macroaxis.com